Divi's Laboratories Statistics
Total Valuation
Divi's Laboratories has a market cap or net worth of INR 1.36 trillion. The enterprise value is 1.33 trillion.
Market Cap | 1.36T |
Enterprise Value | 1.33T |
Important Dates
The next estimated earnings date is Monday, November 4, 2024.
Earnings Date | Nov 4, 2024 |
Ex-Dividend Date | Aug 2, 2024 |
Share Statistics
Divi's Laboratories has 265.47 million shares outstanding. The number of shares has decreased by -0.00% in one year.
Shares Outstanding | 265.47M |
Shares Change (YoY) | -0.00% |
Shares Change (QoQ) | -0.09% |
Owned by Insiders (%) | 49.21% |
Owned by Institutions (%) | 28.55% |
Float | 126.82M |
Valuation Ratios
The trailing PE ratio is 81.47 and the forward PE ratio is 62.95. Divi's Laboratories's PEG ratio is 2.52.
PE Ratio | 81.47 |
Forward PE | 62.95 |
PS Ratio | 16.66 |
PB Ratio | 10.05 |
P/FCF Ratio | n/a |
PEG Ratio | 2.52 |
Enterprise Valuation
EV / Earnings | 79.27 |
EV / Sales | 16.21 |
EV / EBITDA | 56.95 |
EV / EBIT | 68.19 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.02 |
Debt / EBITDA | 0.00 |
Debt / FCF | n/a |
Interest Coverage | 648.67 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 9.23% |
Revenue Per Employee | 8.40M |
Profits Per Employee | 1.72M |
Employee Count | 9,741 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +38.56% in the last 52 weeks. The beta is 0.37, so Divi's Laboratories's price volatility has been lower than the market average.
Beta (5Y) | 0.37 |
52-Week Price Change | +38.56% |
50-Day Moving Average | 4,769.22 |
200-Day Moving Average | 4,073.11 |
Relative Strength Index (RSI) | 65.93 |
Average Volume (20 Days) | 476,432 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Divi's Laboratories had revenue of INR 81.85 billion and earned 16.74 billion in profits. Earnings per share was 63.06.
Revenue | 81.85B |
Gross Profit | 46.68B |
Operating Income | 19.46B |
Pretax Income | 22.75B |
Net Income | 16.74B |
EBITDA | 23.29B |
EBIT | 19.46B |
Earnings Per Share (EPS) | 63.06 |
Balance Sheet
The company has 36.98 billion in cash and 30.00 million in debt, giving a net cash position of 36.95 billion or 139.19 per share.
Cash & Cash Equivalents | 36.98B |
Total Debt | 30.00M |
Net Cash | 36.95B |
Net Cash Per Share | 139.19 |
Equity (Book Value) | 135.71B |
Book Value Per Share | 511.21 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 57.03%, with operating and profit margins of 23.78% and 20.45%.
Gross Margin | 57.03% |
Operating Margin | 23.78% |
Pretax Margin | 27.79% |
Profit Margin | 20.45% |
EBITDA Margin | 28.45% |
EBIT Margin | 23.78% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 30.00, which amounts to a dividend yield of 0.58%.
Dividend Per Share | 30.00 |
Dividend Yield | 0.58% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.00% |
Shareholder Yield | 0.58% |
Earnings Yield | 1.23% |
FCF Yield | n/a |
Stock Splits
The last stock split was on September 23, 2015. It was a forward split with a ratio of 2.
Last Split Date | Sep 23, 2015 |
Split Type | Forward |
Split Ratio | 2 |